Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$786M |
| 2 |
Apple
AAPL
|
+$564M |
| 3 |
Amazon
AMZN
|
+$486M |
| 4 |
Meta Platforms (Facebook)
META
|
+$331M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$327M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Sherwin-Williams
SHW
|
+$1.88B |
| 2 |
Alibaba
BABA
|
+$1.21B |
| 3 |
Home Depot
HD
|
+$320M |
| 4 |
VAR
Varian Medical Systems, Inc.
VAR
|
+$274M |
| 5 |
FLIR
FLIR Systems, Inc. (DE) Common Stock
FLIR
|
+$135M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.98% |
| 2 | Financials | 13.87% |
| 3 | Healthcare | 13.39% |
| 4 | Consumer Discretionary | 11.81% |
| 5 | Communication Services | 10.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TYME
3576
DELISTED
Tyme Technologies, Inc. Common Stock
TYME
| $1.04M | ﹤0.01% |
828,948
-455,682
| -35% | -$657K |
|
|
IMBI
3577
DELISTED
iMedia Brands, Inc. Class A Common Stock
IMBI
| $1.04M | ﹤0.01% |
129,200
+33,073
| +34% | +$267K |
|
|
FONR
3578
DELISTED
Fonar
FONR
| $1.03M | ﹤0.01% |
58,589
-36,929
| -39% | -$659K |
|
3579
Minerva Neurosciences
NERV
$185M
| $1.03M | ﹤0.01% |
55,722
-31,053
| -36% | -$668K |
|
3580
TELA Bio
TELA
$32.7M
| $1.03M | ﹤0.01% |
64,099
-33,468
| -34% | -$459K |
|
|
EH
3581
EHang Holdings
EH
$389M
| $1.03M | ﹤0.01% |
23,910
+9,115
| +62% | +$277K |
|
3582
Hycroft Mining Holding Corp
HYMC
$1.82B
| $1.02M | ﹤0.01% |
33,506
+4,132
| +14% | +$153K |
|
3583
XTI Aerospace
XTIA
$57.3M
| – | – |
0
| – | – |
|
3584
Abeona Therapeutics
ABEO
$366M
| $1.02M | ﹤0.01% |
26,281
-18,087
| -41% | -$738K |
|
|
ESSA
3585
DELISTED
ESSA Bancorp
ESSA
| $1.02M | ﹤0.01% |
62,489
-57,403
| -48% | -$912K |
|
3586
Matinas BioPharma
MTNB
$1.88M
| $1.02M | ﹤0.01% |
26,379
+1,061
| +4% | +$45.6K |
|
3587
Pro-Dex
PDEX
$187M
| $1.02M | ﹤0.01% |
33,448
+4,547
| +16% | +$139K |
|
|
ORAN
3588
DELISTED
Orange
ORAN
| $1.02M | ﹤0.01% |
89,389
+27,928
| +45% | +$349K |
|
3589
Cineverse
CNVS
$56.2M
| $1.02M | ﹤0.01% |
39,610
+5,559
| +16% | +$153K |
|
|
OPTN
3590
DELISTED
OptiNose
OPTN
| $1.02M | ﹤0.01% |
21,891
-15,252
| -41% | -$779K |
|
|
AVGR
3591
DELISTED
Avinger, Inc. Common Stock
AVGR
| $1.02M | ﹤0.01% |
2,767
+15
| +0.5% | +$5.2K |
|
3592
Boxlight
BOXL
$2.03M
| $1.02M | ﹤0.01% |
294
+37
| +14% | +$130K |
|
3593
STMicroelectronics
STM
$46.7B
| $1.02M | ﹤0.01% |
28,018
+1,296
| +5% | +$48.5K |
|
3594
Franklin Financial Services
FRAF
$284M
| $1.02M | ﹤0.01% |
31,839
-24,693
| -44% | -$750K |
|
3595
Super League Enterprise
SLE
$4.28M
| $1.02M | ﹤0.01% |
20
+4
| +25% | +$205K |
|
|
HBP
3596
DELISTED
Huttig Building Products, Inc.
HBP
| $1.01M | ﹤0.01% |
175,757
+48,178
| +38% | +$255K |
|
3597
Dr. Reddy's Laboratories
RDY
$9.87B
| $1.01M | ﹤0.01% |
71,570
-4,910
| -6% | -$68.7K |
|
3598
Cabaletta Bio
CABA
$437M
| $1.01M | ﹤0.01% |
117,662
-84,482
| -42% | -$830K |
|
|
BCLI
3599
DELISTED
BRAINSTORM CELL THERAPUTC
BCLI
| $1.01M | ﹤0.01% |
17,676
-14,208
| -45% | -$759K |
|
|
PTN
3600
Palatin Technologies
PTN
$13.7M
| $1.01M | ﹤0.01% |
1,321
| – | – |
|
Similar funds
Geode Capital Management's Q2 2021 Portfolio in Review
As of Q2 2021, Geode Capital Management held 4,790 positions worth $726B, up 11% from $654B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Geode Capital Management's Q2 2021 filing shows 331 new, 3,384 increased, 720 reduced and 74 closed positions. Its largest new stake was Organon & Co: 5,070,121 shares worth $153M. The largest sale was Sherwin-Williams, an estimated $1.88B.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.
- Geode Capital Management's largest Q2 2021 buy was Organon & Co: 5,070,121 shares worth $153M.
- Geode Capital Management added most to Microsoft in Q2 2021, an estimated $786M increase.
- Geode Capital Management's biggest Q2 2021 reduction was Sherwin-Williams, cutting an estimated $1.88B.
- Geode Capital Management fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $274M.
- Geode Capital Management's ten largest holdings make up 22% of its $726B portfolio in Q2 2021.
- Geode Capital Management opened 331 new positions and closed 74 in Q2 2021.
- Geode Capital Management's portfolio value rose 11% quarter-over-quarter to $726B.
Based on Geode Capital Management's 13F filing for Q2 2021, filed 13 Aug 2021.